| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/28/2004 | EP1383377A1 Compositions including vitamin-based surfactants and methods for using same |
| 01/28/2004 | EP1383376A2 Pharmaceutical formulations for sustained release |
| 01/28/2004 | EP1383375A1 A release pharmaceutical construct for gastric retention |
| 01/28/2004 | EP1345589A4 Solvent systems for pharmaceutical agents |
| 01/28/2004 | EP1307097A4 Improved solid pharmaceutical dosage formulation of hydrophobic drugs |
| 01/28/2004 | EP1267798A4 Treatment of skin damage using polyenylphosphatidylcholine |
| 01/28/2004 | EP1217990B1 Cationic dosper virosomes |
| 01/28/2004 | EP1089718B1 Sticking plaster for controlled release of natural interferon |
| 01/28/2004 | EP1071397B1 Controlled release peroral compositions of levosimendan |
| 01/28/2004 | EP1058541B1 Sustained-release preparation for aii antagonist, production and use thereof |
| 01/28/2004 | EP0994657B1 Palatable elemental medical food |
| 01/28/2004 | EP0957900B1 Compositions and methods for topical application of therapeutic agents |
| 01/28/2004 | EP0921789B1 Taste masked liquid suspensions |
| 01/28/2004 | EP0918790B1 Polycationic sterol derivatives as transfection agents |
| 01/28/2004 | EP0871428B1 Preparation used in dental care |
| 01/28/2004 | EP0839028B1 Solid dispersions of rapamycin |
| 01/28/2004 | EP0782442B1 A delivery system for antimethanogenic agents comprising cyclodextrin and antimethanogenic agents |
| 01/28/2004 | EP0760842B1 Improved long acting gi and esophageal protectant |
| 01/28/2004 | EP0708637B1 Self-assembling polynucleotide delivery system comprising dendrimer polycations |
| 01/28/2004 | CN2601094Y Compound capsule |
| 01/28/2004 | CN1471413A Devices, systems and methods for patient infusion |
| 01/28/2004 | CN1471405A Suspension of an EPI-HNE protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical composition containing said suspension or aerosol, and their uses |
| 01/28/2004 | CN1471403A Oral preparation containing seaweed for reduction of plaque and calculus |
| 01/28/2004 | CN1471401A Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
| 01/28/2004 | CN1471398A Controlled release formulations for oral administration |
| 01/28/2004 | CN1471389A Ibuprofen solutions for capsule-filling and capsule preparations |
| 01/28/2004 | CN1471388A Milled particles |
| 01/28/2004 | CN1471387A Oral dosage self-emulsifying formulations of pyranone proteinase inhibitors |
| 01/28/2004 | CN1470513A Total alkaloid with anticancer activity and its formulation |
| 01/28/2004 | CN1470289A Polymeric nano medicine carrier and preparation preparing method |
| 01/28/2004 | CN1470280A Rhizome alismatis capsule and pill, and its preparing method and use |
| 01/28/2004 | CN1470273A Medicine for treating gynaopathy and its preparation use thereof |
| 01/28/2004 | CN1470272A Fat-reducing are blood-circulation promoting capsule |
| 01/28/2004 | CN1470259A Medical thread and its preparation method and its use in treatnig hyperosteogeny and relative diseases |
| 01/28/2004 | CN1470258A Chinese medicine for treating chest paralysis |
| 01/28/2004 | CN1470246A Liquid antiacid composition |
| 01/28/2004 | CN1470245A Low-molecular-weight chondroitin sulfate injecta and its preparation method |
| 01/28/2004 | CN1470240A Controllable release system of glucocorticoid and its preparation and use |
| 01/28/2004 | CN1470238A Levosimendan formulation and its preparing method |
| 01/28/2004 | CN1470234A Capsaicin liposome preparation for skin |
| 01/28/2004 | CN1470233A Water-soluble medicine particle-type slow-release composition, preparation and its preparing method |
| 01/28/2004 | CN1470180A Tea beverage effervescent tablets and its preparation method |
| 01/28/2004 | CN1136217C 4-aryloxindoles as inhibitor of JNK protein kinases |
| 01/28/2004 | CN1136010C Method for making Subunit antigen vaccine cream |
| 01/28/2004 | CN1136006C Externally applied chinese medicine decoction |
| 01/28/2004 | CN1135999C Medicine for treating chicken disease of respiratory tract |
| 01/28/2004 | CN1135992C Dressing for treating infantile bronchitis and pulmonitis and its preparation |
| 01/28/2004 | CN1135991C Oral liquid for preventing and curing senile dementia and its preparing process |
| 01/28/2004 | CN1135988C Use of botulinum toxin in preparing pharmaceutical composition for treating prostatic disorders |
| 01/28/2004 | CN1135986C Vaginal minocycline suppository |
| 01/28/2004 | CN1135984C O/W emulsion composition for eye drops |
| 01/28/2004 | CN1135981C Morphine sulphate microgranules, and method for making same and pharmaceutical preparations |
| 01/28/2004 | CN1135980C Berberine hydrochloride suppository and its producing method |
| 01/28/2004 | CN1135978C Lubricating cream for copulation |
| 01/28/2004 | CN1135971C Transdermal preparation containing serotonin receptor antagonist |
| 01/28/2004 | CN1135970C Use of micro particles having a protein and an antiboby absorbed theron for preparing a pharmaceutical composition for intranasal administration |
| 01/28/2004 | CN1135969C Aqueous pharmaceutical composition comprising active ingredient which is highly insoluble in water |
| 01/27/2004 | USRE38407 Administering composition containing liposome-encapsulated opioid analgesic agent through patient's pulmonary system |
| 01/27/2004 | US6683215 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 01/27/2004 | US6683144 Salts of acrylamidoalkylsulfonic acids and cyclic or linear n-vinylcarboxamides monomers with crosslinkers having multiple double bonds; thickeners, emulsion and dispersion stabillizers and as glidants in cosmetic and pharmaceuticals |
| 01/27/2004 | US6683112 Gabapentin prodrugs and formulations |
| 01/27/2004 | US6683103 Sulfonamides containing oxazole and substituted thiophene rings, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure |
| 01/27/2004 | US6683100 Organic compounds |
| 01/27/2004 | US6683070 Suspension of water insoluble drug and water soluble polymer; reducing drug concentration, surface tension |
| 01/27/2004 | US6683067 Formulations for treating or preventing mucositis |
| 01/27/2004 | US6683064 First polysaccharide crosslinked to second polysaccharide, selected from hyaluronic acid, dextran, dextran sulfate, chondroitin sulfate, dermatan sulfate, keratan sulfate, heparin, heparan sulfate and alginate |
| 01/27/2004 | US6683063 Lipopolysaccharide disorders |
| 01/27/2004 | US6683062 Attaching a bioeffecting agent to a substrate with an anchor provided by a linker compound which also forms a cleavable linkage so that the drug has a sustained release; anti-thrombogenic, -imicrobial, -inflammatory agents |
| 01/27/2004 | US6683052 Lipopeptides containing an interferon-γ fragment, and uses thereof in pharmaceutical compositions |
| 01/27/2004 | US6682761 Water-insoluble drug particle process |
| 01/27/2004 | US6682759 Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs |
| 01/27/2004 | US6682758 Water-insoluble drug delivery system |
| 01/27/2004 | US6682757 Patch units |
| 01/27/2004 | US6682756 Flexible; break and tear resistant; storage stable |
| 01/27/2004 | US6682754 Ovo delivery of an immunogen containing implant |
| 01/27/2004 | US6682750 Surfactant-free cosmetic, dermatological and pharmaceutical compositions |
| 01/27/2004 | US6682747 Process for preparing an oral suspension of a pharmaceutical substance |
| 01/27/2004 | US6682718 Alveolar mucosa injection of bisphosphonic acid derivative and such as incadronic acid |
| 01/27/2004 | US6682716 Delivery of aerosols containing small particles through an inhalation route |
| 01/27/2004 | US6682522 For controlled delivery of a beneficial agent(such as drugs) |
| 01/27/2004 | US6682521 Temperature activated systems |
| 01/27/2004 | US6682500 Synthetic muscle based diaphragm pump apparatuses |
| 01/27/2004 | US6682348 Dispensing apparatus and cartridge |
| 01/27/2004 | US6681549 Method and system with electronic control devices for blending of Chinese medicine |
| 01/27/2004 | CA2267083C Method for releasing an active principle contained in a multiple emulsion |
| 01/27/2004 | CA2254772C Liposomal antineoplaston therapies with markedly improved antineoplastic activity |
| 01/27/2004 | CA2179682C Pharmaceutical, orally applicable composition |
| 01/27/2004 | CA2144094C Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract |
| 01/27/2004 | CA2123739C Formulations containing carotenoids and procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals |
| 01/27/2004 | CA2120048C Pharmaceutical composition having analgesic activity |
| 01/27/2004 | CA2105374C Method of producing sustained-release microcapsules |
| 01/27/2004 | CA2081921C Improvements in or relating to electrostatic coating of substrates of medicinal products |
| 01/26/2004 | CA2395871A1 Substituted indolealkanoic acids derivatives and formulations containing same for use in treatment of diabetic complications |
| 01/22/2004 | WO2004007593A1 Poly-gamma-glutamate having ultra high molecular weight and method for using the same |
| 01/22/2004 | WO2004007588A1 Biodegradable phase separated segmented multi block co-polymers |
| 01/22/2004 | WO2004007520A2 Methods and compositions for preventing oxidative degradation of proteins |
| 01/22/2004 | WO2004007185A1 A tablet press machine |
| 01/22/2004 | WO2004006990A2 Medical device and method for tissue removal and repair |
| 01/22/2004 | WO2004006973A1 Resorbable structure for treating and healing of tissue defects |
| 01/22/2004 | WO2004006964A1 Microbubble compositions, and methods for preparing and using same |